Journal
Human Vaccines & Immunotherapeutics
Publication Date
5-19-2022
Volume
18
Issue
5
First Page
2072143
Document Type
Open Access Publication
DOI
10.1080/21645515.2022.2072143
Rights and Permissions
Plüß M, Piantoni S, Tampe B, Kim AHJ, Korsten P. Belimumab for systemic lupus erythematosus - Focus on lupus nephritis. Hum Vaccin Immunother. 2022 Nov 30;18(5):2072143. doi: 10.1080/21645515.2022.2072143. © 2022 The Author(s). Published with license by Taylor & Francis Group, LLC. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
Recommended Citation
Plüß, Marlene; Piantoni, Silvia; Tampe, Björn; Kim, Alfred H J; and Korsten, Peter, "Belimumab for systemic lupus erythematosus - Focus on lupus nephritis." Human Vaccines & Immunotherapeutics. 18, 5. 2072143 (2022).
https://digitalcommons.wustl.edu/oa_4/3439
Department
ICTS (Institute of Clinical and Translational Sciences)
